Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis
Public ClinicalTrials.gov record NCT02830477. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multinational Phase IV Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to investigate weekly prophylaxis dosing regimens used in standard clinical practice. In addition the study will capture reported bleed rate, pattern of change in KOVALTRY prophylaxis dose \& dosing frequency, reason for choice of treatment regimen, FVIII product switch pattern, patient treatment satisfaction and adherence, KOVALTRY pharmacokinetic data (if performed), KOVALTRY consumption, as well as safety data.
Study identification
- NCT ID
- NCT02830477
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 313 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 14, 2016 (Actual)
- Primary completion
- Dec 1, 2020 (Actual)
- Completion
- Mar 1, 2021 (Actual)
- Last update posted
- Nov 7, 2023
2016 – 2021
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Rehabilitation Services/ University of South Alabama | Mobile | Alabama | — | — |
| University of Colorado Hemophilia and Thrombosis Center | Aurora | Colorado | — | — |
| University of Florida Health Cancer Center | Gainesville | Florida | — | — |
| Nemours Children's Clinic - Division of Pediatric Hematology/Oncology - Jacksonsville | Jacksonville | Florida | — | — |
| Nemours Children's Clinic - Pensacola | Pensacola | Florida | — | — |
| Henry Ford Hospital Adult Hemophilia and Thrombosis Treatment Center | Detroit | Michigan | — | — |
| Washington University Center for Bleeding and Blood Clotting Disorders | St Louis | Missouri | — | — |
| Hemophilia Center of Western New York | Buffalo | New York | — | — |
| East Carolina University - Brody School of Medicine | Greenville | North Carolina | — | — |
| Wake Forest University School of Medicine | Winston-Salem | North Carolina | — | — |
| Children's Hospital at OU Medical Center | Oklahoma City | Oklahoma | — | — |
| Intermountain Hemophilia & Thrombosis Center | Salt Lake City | Utah | — | — |
| Comprehensive Center for Bleeding Disorders / Blood Center of Wisconsin | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02830477, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 7, 2023 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02830477 live on ClinicalTrials.gov.